Abstract

<p>This review article aims to provide an update on the sources, pharmaco-logical and biological profile of a β-carboline alkaloid, harmine which is a major bioactive component of various plants mainly Peganum harmala. Harmine’s wide range of pharmacological properties has been well-documented as anti-cancer, anti-inflammatory, anti-oxidant, neuroprotective, anti-depressant, and antimicrobial. Although reported data suggests a multifunctional pharmacological role of harmine but farther experimentation on its molecular mechanism of action, synthetic chemistry approaches, and preclinical studies are yet obligatory to fully uncover its pharmacological efficacy.</p>

Highlights

  • Natural products have served humanity as a fundamental source of medicine throughout the history of civilization

  • Structure-activity relationship of harmine derivatives has been established by TD-DFT study (Lamchouri et al, 2013) and this study showed that position-3 and 9 played a crucial role in antitumor as well as neurotoxicity of harmine derivatives

  • Aggregated data indicated that harmine demonstrates pronounced anti-proliferative effects in MCF-7 cells which are associated with the prohibition of telomerase activity

Read more

Summary

Introduction

Natural products have served humanity as a fundamental source of medicine throughout the history of civilization. Harmine showed anti-proliferative activity towards thyroid TPC-1 cells via down-regulation of Bcl2 dose-dependently (Ruan et al, 2017). An optimized harmine derivative, CM16’s anti-cancer activity was assessed against oligodendroglioma (Hs683), breast adenocarcinoma (MDA-MB231), and melanoma (SKMEL-28) cell lines.

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.